Ischemic Stroke Market 2027: Growth, Trends, Key Player Advanced Technologies and Innovations

 

Ischemic strokes occur when an artery or blood vessel supplying blood to the brain is blocked. The brain is dependent on the arteries to bring fresh blood from the lungs and heart. A blockage in the same causes ischemic stroke. The underlying reason behind such obstruction is the development of fatty deposits lining the vessel walls, also known as atherosclerosis.

A research by the World Health Organization (WHO) states that around 17 million deaths have been noticed annually due to strokes. The higher mortality rate associated with strokes showcases an impending need for new and innovative drugs and diagnostic devices. As per the latest report released by Market Research Future (MRFR), the global Ischemic stroke market is expected to attain a CAGR of approximately 8.3% during the forecast period between 2017 and 2023.

The evolving lifestyle of individuals, prevalence of diabetes, increasing ageing population, and high tobacco usage are the major factors driving the market. Additionally, the increasing demand for minimally invasive procedures and advancements in surgical procedures are some of the key factors accelerating the growth of the global market. However, the high cost associated with such surgical procedures and the excessive medicinal usage for the treatment of the condition is reported as a major hindrance to the market growth.

Get Sample Copy of Report @ https://www.marketresearchfuture.com/sample_request/5423

Major Players

Some of the leading giants driving the ischemic stroke market include GE Healthcare, Genentech, Koninklijke Philips N.V., Johnson & Johnson, Boston Scientific Corporation, Hitachi, Ltd, Penumbra, Inc., Sanofi, Siemens Healthcare, Daiichi Sankyo, Bayer AG, Pfizer Inc., Stryker Corporation, Cordis Corporation, Boehringer Ingelheim, Philips Healthcare, Covidien plc, Biogen, Medtronic plc, Abbott Laboratories, and GE Healthcare.

Market Segmentation

The global ischemic stroke market is majorly segmented based on diagnosis, surgery, drug class, and end-users.

  • The Diagnosis segment is bifurcated into carotid ultrasound, echocardiography, cerebral angiography, Magnetic resonance imaging (MRI), Computed Tomography (CT), electrocardiography, and echocardiography.
  • Based on its Drug Class, the global ischemic stroke market is classified into antihypertensive, anticoagulant, antihypertensive, and tissue plasminogen activator, and others.
  • Based on Surgery, the global market is divided into endovascular mechanical thrombectomy, carotid endarterectomy, and angioplasty.
  • Further, the global ischemic stroke market’s End-user segment is segmented into research organizations, hospitals & clinics, medical institutes, and others.

Regional Analysis

The global ischemic stroke market is geographically segmented into the following regions: Asia Pacific, America, Europe, and the Middle East and Africa.

The Americas is reported to be the largest market for ischemic stroke due to technological innovations, favorable government initiatives, and rising demand for ischemic stroke products.

Europe holds the second largest share of the market and is expected to hold on to the same in the forthcoming years due to numerous factors. Rising prevalence of acute ischemia stroke cases and advancements in the surgical device technology are two key factors driving the market herein. Other driving factors of the market in this region is the growing number of diabetes mellitus population primarily in the developed nations of Europe.

Get Access Full Report @ https://www.marketresearchfuture.com/reports/ischemic-stroke-market-5423

Asia Pacific is identified to witness the most promising growth in the forecast period to cement its place in the global ischemic stroke market. The proliferating growth of the region can be attributed to the widespread prevalence of stroke cases in the Asia Pacific region. Both China and India are two of the major contributors to the regional market and will play major roles in accelerating the overall Asia Pacific region. Manufacturers are quickly realizing the potential this region holds and are expanding their operations therein to capitalize on the same.

The Middle East region is anticipated to grow at a fast rate owing to factors like increasing emphasis on research and development activities in the healthcare sector and continuous development of the healthcare infrastructure.

Comments

Post a Comment

Popular posts from this blog

Catheters Market Emerging Technologies, Size and Market Segments by Forecast 2030

Image
  Catheters are medical devices inserted into the human body during treatment of diseases. It is also used in pre-, post-, and during surgical procedures. Modification of catheters by changing the type of material used in its manufacture can extend its application for ophthalmic, neurological, cardiovascular, gastrointestinal, and urological procedures. The global   catheters market report   by Market Research Future (MRFR) contains opportunities, trends, drivers, and restraints and an analysis at regional and country levels. The global  catheters market  is expected to touch a towering valuation by exhibiting 6.14% CAGR from the forecast period. It can touch a valuation of USD 49,731.9 million by end. Rising incidence of cardiovascular diseases and other malaises can drive the market growth exponentially. According to the American College of Cardiology, cardiovascular related deaths accounted for 31% of global mortality statistics. This is supported with record...
Read more

Infrared Spectroscopy Devices Market Size, Share, Price, Revenue, Growth Analysis by 2027

Image
  Market Research Future (MRFR) in their report on the   infrared spectroscopy devices market size   predicted a 7.2% CAGR during the forecast period. The infrared spectroscopy devices market is expected to cross a valuation of USD 1821 million by the end. optical emission spectroscopy devices ensure interaction between infrared spectroscopy and matter. Mostly based on the absorption technology, the method can be used to study properties of chemicals, be it solid, liquid, or gaseous.  The  IR spectroscopy devices  creates a spectrum which can be read through a light absorbance graph. By matching the resonant frequency of the spectroscopy with the vibrational frequency of molecules, the method helps in identifying the nature of the molecule. The technology is quite popular in both organic and inorganic chemistry. MRFR while discussing the report included detailed segmental analysis, along with an in-depth study of the factors that can promote the market subs...
Read more

CA 125 Test Market Revenue, Price and Gross Margin Study with Forecasts to 2027

Image
  Cancer diagnosis and treatment has extensively evolved in the last few years owing to the development of methods for diagnostics and treatment. Research on cancer has received large emphasis due increasing demand for chemotherapy drugs and evolution of technology. There are various methods for the diagnosis of different types of cancer.   CA 125 test market   is used to diagnosis various types of cancers especially the ovarian cancer. The test determines the levels of CA 125 protein the blood. Other cancers that can be diagnosed using CA 125 tests are endometrial cancer, fallopian tube cancer, stomach cancer, breast cancer, and others. The global  CA 125 test market size  is expected to grow at a CAGR of 5.7% during the forecast period. Taste the market data and market information presented through more than 55 market data tables and figures spread over 101 pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “CA 125 ...
Read more